Explore the latest F&O Tracker insights as market sentiment remains constructive, with Nifty and Bank Nifty showing mixed momentum.

The pharma sector appears to be entering a fresh leg of the uptrend, especially given its consistent outperformance over the ...

BEAT has become the top gainer of the day after climbing more than 35% over the past 24 hours despite weakness across most ...

The trends on Gift Nifty also indicate a positive start for the Indian benchmark index. The Gift Nifty was trading around 24,150 level, a premium of nearly 93 points from the Nifty futures’ previous ...

The market is expected to remain range-bound with a positive bias after the strong two-day rally. Below are some short-term trading ideas to consider.

Getting pregnant can be a beautiful and life-changing moment for most women. It often represents the beginning of a new chapter filled with hopes, dreams, and the anticipation of welcoming a new life.

Understanding the patterns of acquired resistance to epidermal growth factor receptor (EGFR) TKI treatment has led to more effective combination therapy and continues to drive development of novel ...

Tech resumed its leadership, and traders weighed a reported agreement between U.S. and Iranian negotiators to extend the ceasefire.

Julia is the associate news editor for Health, where she edits and publishes news articles on trending health and wellness topics. Her work has been featured in The Heights, an independent student ...

The Greeks (which include delta, gamma, theta, vega, and rho) provide a way to measure the sensitivity of an option's price ...

In this segment, Dr. Gregory Vidal outlines what a typical first-line treatment plan looks like for patients with ER-positive, HER2-negative metastatic breast cancer. In this segment, Dr. Gregory ...

Retatrutide has cleared a large hurdle in TRANSCEND-T2D-1, the first phase III trial testing the triple hormone receptor agonist in patients with type 2 diabetes, according to new top-line results ...